Treatment of Parkinson's disease.
Boyson
S J
SJ
D000978:Antiparkinson Agents / Q000627:therapeutic use; D002230:Carbidopa / Q000009:adverse effects / Q000627:therapeutic use; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004873:Ergolines / Q000627:therapeutic use*; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D008090:Lisuride / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D004338:Drug Combinations; D004873:Ergolines; C009265:carbidopa, levodopa drug combination; D007980:Levodopa; D008090:Lisuride; D002230:Carbidopa